AD
Therapeutic Areas
Algipharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| OligoG (Inhaled) | Cystic Fibrosis | Phase 2 |
| OligoG Platform | Infectious Diseases / Biofilm Disruption | Clinical |
| Drug | Indication | Phase |
|---|---|---|
| OligoG (Inhaled) | Cystic Fibrosis | Phase 2 |
| OligoG Platform | Infectious Diseases / Biofilm Disruption | Clinical |